144 related articles for article (PubMed ID: 8638984)
1. [Comparison of routine therapeutic protocols used in Madagascar for the treatment of smear-positive pulmonary tuberculosis (preliminary results)].
Boisier P; Rabarijaonal L; Rakotomanana F; Ratsitorahina M; Ratsirahonana O; Roux J; Auregan G
Arch Inst Pasteur Madagascar; 1995; 62(1):72-6. PubMed ID: 8638984
[TBL] [Abstract][Full Text] [Related]
2. Replacement of streptomycin by ethambutol in the intensive phase of tuberculosis treatment: no effect on compliance.
Rabarijaona L; Boisier P; Ratsirahonana O; Razafinimanana J; Rakotomanana F; Ratsitorahina M; Ramarokoto H; Cauchoix B; Aurégan G
Int J Tuberc Lung Dis; 1999 Jan; 3(1):42-6. PubMed ID: 10094168
[TBL] [Abstract][Full Text] [Related]
3. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
Shah AR; Agarwal SK; Shah KV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
[TBL] [Abstract][Full Text] [Related]
4. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis?
Wilkinson D; Bechan S; Connolly C; Standing E; Short GM
Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111
[TBL] [Abstract][Full Text] [Related]
5. [Mycobacterium tuberculosis resistance to antitubercular agents in Antananarivo in 2000].
Ratsirahonana O; Rasolofo Razanamparany V; Rasolonavalona T; Rakotonirina V; Rakotoarisaonina A; Rakotoherisoa A; Ralamboson M; Cauchoix B; Rakotondramarina D; Ramarokoto H
Arch Inst Pasteur Madagascar; 2002; 68(1-2):44-7. PubMed ID: 12643091
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda.
Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S
East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516
[TBL] [Abstract][Full Text] [Related]
7. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
Singla R; Al-Sharif N; Al-Sayegh MO; Osman MM; Shaikh MA
Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
[TBL] [Abstract][Full Text] [Related]
8. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako].
Kayantao D; Keïta B; Sangaré S
Bull Soc Pathol Exot; 1997; 90(2):124-7. PubMed ID: 9289251
[TBL] [Abstract][Full Text] [Related]
9. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
[TBL] [Abstract][Full Text] [Related]
10. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report.
Ige OM; Bakare NA; Onadeko BO
Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study on efficacy of regimens including streptomycin or ethambutol].
Li Q; Xiao C; Song W
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):76-8. PubMed ID: 11263387
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
[TBL] [Abstract][Full Text] [Related]
13. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment.
Ramarokoto H; Randriamiharisoa H; Rakotoarisaonina A; Rasolovavalona T; Rasolofo V; Chanteau S; Ralamboson M; Cauchoix B; Rakotondramarina D
Int J Tuberc Lung Dis; 2002 Oct; 6(10):909-12. PubMed ID: 12365578
[TBL] [Abstract][Full Text] [Related]
14. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
[TBL] [Abstract][Full Text] [Related]
15. Mortality and failure among tuberculosis patients who did not complete treatment in Vietnam: a cohort study.
Vree M; Huong NT; Duong BD; Sy DN; Van le N; Co NV; Cobelens FG; Borgdorff MW
BMC Public Health; 2007 Jul; 7():134. PubMed ID: 17605770
[TBL] [Abstract][Full Text] [Related]
16. The microbiological and clinical effects of combined therapy according to guidelines on the treatment of pulmonary Mycobacterium avium complex disease in Japan - including a follow-up study.
Kobashi Y; Matsushima T
Respiration; 2007; 74(4):394-400. PubMed ID: 16954651
[TBL] [Abstract][Full Text] [Related]
17. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
18. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
Gubkina MF; Ershova NG
Probl Tuberk Bolezn Legk; 2009; (1):33-6. PubMed ID: 19256010
[TBL] [Abstract][Full Text] [Related]
19. [Profile of the patients lost to treatment in the National Anti-Tuberculosis Program in Madagascar].
Rakotomanana F; Rabarijaona LP; Ratsitorahina M; Cauchoix B; Razafinimanana J; Ratsirahonana A; Boisier P; Aurégan G
Sante; 1999; 9(4):225-9. PubMed ID: 10623869
[TBL] [Abstract][Full Text] [Related]
20. [Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis].
Ouedraogo M; Ouedraogo SM; Diagbouga S; Coulibaly G; Achi V; Domoua K; N'Dathz M; Yapi A
Rev Mal Respir; 2000 Apr; 17(2):477-80. PubMed ID: 10859766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]